TUESDAY, Sept. 24, 2019 (HealthDay News) — The recall of the commonly prescribed blood pressure drug losartan has been expanded once again to include an additional five lots.
The drug, made by Torrent Pharmaceuticals, has been recalled because some lots are contaminated with the cancer-causing chemical N-methylnitrosobutyric acid, according to a company press release.
The drugs added to the recall include lots of Losartan Potassium Tablets, USP, and Losartan Potassium/Hydrochlorothiazide Tablets, USP, all of which have amounts of the contaminant that exceed FDA-recommended levels.
This recall is the fifth for losartan that Torrent has announced this year.
Copyright © 2019 HealthDay. All rights reserved.